Atisama Therapeutics is a startup based in Australia.
Atisama Therapeutics develops splice-switching oligonucleotide therapies that modulate gene transcription to restore molecular balance and treat chronic inflammatory diseases.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.